Metraipolis › archive › dc_61d7afe8947d

Disseminate Cutaneous Vasculitis Associated with Durvalumab Treatment-Case Report, Mini-Review on Cutaneous Side Effects of Immune Checkpoint Inhibitor… — Europe PMC PMID:39337847

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/39337847
DOI
10.3390/life14091062
License (as archived)
solo-consultazione
Archived
2026-10-07T18:35:03.514Z
SHA-256 of the archived text
f3d5983281d3a7d71c19fdddbc4d0e5c73d8f258d3c1c4f432216e8e867efda2
Stable URL of this page
https://metraipolis.com/documento/dc_61d7afe8947d

How to cite

Disseminate Cutaneous Vasculitis Associated with Durvalumab Treatment-Case Report, Mini-Review on Cutaneous Side Effects of Immune Checkpoint Inhibitor… — Europe PMC PMID:39337847 — Europe PMC (en), https://europepmc.org/article/MED/39337847 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_61d7afe8947d (Metraipolis archive dc_61d7afe8947d, sha256 f3d5983281d3a7d71c19fdddbc4d0e5c73d8f258d3c1c4f432216e8e867efda2)
BibTeX
@misc{dc61d7afe8947d,
  title = {Disseminate Cutaneous Vasculitis Associated with Durvalumab Treatment-Case Report, Mini-Review on Cutaneous Side Effects of Immune Checkpoint Inhibitor… — Europe PMC PMID:39337847},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/39337847},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_61d7afe8947d; sha256 f3d5983281d3a7d71c19fdddbc4d0e5c73d8f258d3c1c4f432216e8e867efda2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/39337847. Agents can read the archived copy with the MCP tool read_document.